New Zealand vs Sierra Leone: Prevalence rate of diabetes in adults
New Zealand
6.9
in 2014
Sierra Leone
6.9
in 2014
New Zealand rank
142nd
Sierra Leone rank
142nd
Prevalence rate of diabetes in adults over time
- New Zealand
- Sierra Leone
How they compare
New Zealand currently reports 6.9 against 6.9 in Sierra Leone, a difference of 0.
The two have swapped places 1 time across 35 shared years of data; in 1980 it was New Zealand ahead.
New Zealand ranks 142nd and Sierra Leone ranks 142nd of 190 countries.
New Zealand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | New Zealand | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 5.54 | 3.68 | 1.86 | New Zealand |
| 1990s | 6.1 | 4.55 | 1.55 | New Zealand |
| 2000s | 6.67 | 5.6 | 1.07 | New Zealand |
| 2010s | 6.84 | 6.56 | 0.28 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, New Zealand or Sierra Leone?
- New Zealand, at 6.9 against 6.9 in Sierra Leone as of 2014.
- What is the difference in prevalence rate of diabetes in adults between New Zealand and Sierra Leone?
- 0, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Sierra Leone?
- 35 years are reported by both, from 1980 to 2014.
- How do New Zealand and Sierra Leone rank globally for prevalence rate of diabetes in adults?
- New Zealand ranks 142nd and Sierra Leone ranks 142nd of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.